[1]马玉琴*,李亚琴,李美琴,等.低分子肝素钠预防妇科肿瘤围手术期下肢深静脉血栓的疗效与安全性[J].中国计划生育和妇产科,2018,(11):43-46.
　MA Yu-qin*,LI Ya-qin,LI Mei-qin,et al.Efficacy and safety of low molecular weight heparin in prevention of deep vein thrombosis in gynecologic tumors during perioperative period[J].Chinese Journal of Family Planning & Gynecotokology,2018,(11):43-46.
点击复制

低分子肝素钠预防妇科肿瘤围手术期下肢深静脉血栓的疗效与安全性
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年11期
页码:
43-46
栏目:
论著与临床
出版日期:
2018-11-25

文章信息/Info

Title:
Efficacy and safety of low molecular weight heparin in prevention of deep vein thrombosis in gynecologic tumors during perioperative period
作者:
马玉琴1*; 李亚琴1; 李美琴1; 刘曼华2
1.226500江苏南通，如皋市人民医院妇产科；2.226000江苏南通，南通市第一人民医院妇产科
Author(s):
MA Yu-qin1*; LI Ya-qin1 ; LI Mei-qin1; LIU Man-hua2
1.Department of Gynaecology and Obstetrics ，Rugao People's Hospital，Nantong Jiangsu 226500；2.Department of Gynecology and Obstetrics，Nantong First People's Hospital，Nantong Jiangsu 226000，P.R.China
关键词:
妇科肿瘤; 下肢深静脉血栓; 低分子肝素钠; 疗效; 安全性
Keywords:
gynecologic tumor; deep venous thrombosis of lower extremity; low molecular heparin sodium; efficacy; safety
分类号:
R 713
摘要:
目的探讨低分子肝素钠预防妇科肿瘤围手术期下肢深静脉血栓（lower extremity deep venous thrombosis of lower extremity, LEDVT）的临床效果和用药安全性。方法选择2015年1月至2017年4月如皋市人民医院和南通市第一人民医院行手术治疗的84例妇科肿瘤患者，根据入院日期单双数分成两组，各42例，对照组围手术期给予常规治疗处理，观察组在此基础上预防性使用低分子肝素钠。观察两组患者手术前后凝血功能和纤溶系统指标的变化，术后LEDVT的发生率以及药物不良反应。 结果用药1周后两组的凝血酶原时间、活化部分凝血活酶时间和纤维蛋白原等凝血指标，以及D-二聚体、抗凝血酶Ⅲ和组织型纤溶酶原激活物等纤溶系统指标比较，差异有统计学意义（P＜005）；术后1周内观察组的LEDVT发生率（476 %）明显低于对照组（143 %），差异有统计学意义（P＜005）；两组不良反应发生率比较，差异无统计学意义（P＞005）。结论妇科肿瘤患者在围手术期预防性使用低分子肝素钠，能改善患者的凝血和纤溶系统指标，降低术后LEDVT发生率，促进疾病恢复，用药安全性较高，可作为妇科肿瘤围手术期防治LEDVT的预防性用药。
Abstract:
ObjectiveTo explore the clinical efficacy and safety of low molecular weight heparin in preventing deep vein thrombosis (LEDVT) of gynecological tumors during perioperative period. Methods84 cases of gynecologic tumor patients in Rugao People's Hospital and Nantong First People's Hospital from January 2015 to April 2017 were divided into two groups according to the single and even number of admission dates,with 42 cases in each group. The control group was treated with routine treatment during the perioperative period. The observation group used prophylactic use of low molecular weight heparin sodium on this basis. The changes of coagulation function and fibrinolytic system index before and after operation, the incidence of postoperative LEDVT and adverse drug reactions were observed. Results1 weeks after medication, the prothrombin time, activated partial thromboplastin timeand fibrinogen, as well as D- two polymer,The indexes of fibrinolytic system, such as total name of antithrombin III, and tissue type plasminogen activator were compared, and the differences were statistically significant(P<005), and the incidence of LEDVT in the observation group was significantly lower within 1 weeks after the operation. In the control group, the difference was statistically significant(P<005); there was no significant difference in the adverse reaction rate between the two groups(P>005). ConclusionThe preventive use of low molecular weight heparin sodium in the perioperative period of gynecologic tumor can improve the index of coagulation and fibrinolysis, reduce the incidence of DVT in the lower extremities, promote the recovery of the disease, and have high safety. It can be used as a precontrol drug for the prevention and treatment of lower extremity DVT in the perioperative period of gynecologic tumor.

参考文献/References:

［1］黄静，阳志军，张洁清，等．妇科恶性肿瘤并发深静脉血栓形成的危险因素及预后影响因素分析 ［J］．中华妇产科杂志，2015，50 （10）：762-769． ［2］PRESCOTT L S, KIDIN L M, DOWNS R L, et al. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence ［J］. International Journal of Gynecological Cancer,2015, 25 (1): 152-159. ［3］中华医学会外科学分会血管外科组．2012深静脉血栓形成的诊断和治疗指南 ［J］．中华外科杂志，2012，50 （7）：611-612． ［4］周惠玲，程秀华，甘燕玲，等．经络弹力袜预防老年妇女妇科肿瘤术后下肢深静脉血栓形成的效果 ［J］．中国老年学杂志，2014，34 （20）：5882-5883． ［5］郑虹，高雨农，燕鑫，等．术后应用低分子肝素联合逐级加压弹力袜预防妇科恶性肿瘤患者静脉血栓栓塞性疾病 ［J］．中华肿瘤杂志，2014，36 （1）：39-42． ［6］SANFORD D, NAIDU A, ALIZADEH N, et al. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials ［J］. Journal of Thrombosis and Haemostasis : JTH, 2014, 12 (7): 1076-1085. ［7］丁冠男，李树人，潘振祥，等．巴曲亭对低分子肝素抗凝全髋置换术患者出血量及凝血功能影响的研究 ［J］．中华流行病学杂志，2014，36 （6）：737-740． ［8］陈吉牟，狄文．预防性抗凝治疗在妇科恶性肿瘤中的应用 ［J］．国际妇产科学杂志，2015，42 （5）：579-582． ［9］何红芬．妇科肿瘤术后患者凝血功能变化的临床观察 ［J］．昆明医科大学学报，2016，37 （1）：90-93． ［10］豆晓蕾．丹参联合低分子肝素预防妇科盆腔术后下肢深静脉血栓形成临床观察 ［J］．中国现代医生，2013，51 （16）：64-66． ［11］贾西彪，王红静．妇科肿瘤术后静脉血栓栓塞性疾病诊治及预防的研究进展 ［J］．实用妇产科杂志，2015，31 （1）：23-25． ［12］林素云．低分子肝素钙预防妇科肿瘤术后深静脉血栓的效果观察 ［J］．中华全科医学，2015，13 （11）：1904-1906． ［13］文伟能，冯健珊．观察低分子肝素钠预防妇科盆腔手术后下肢深静脉血栓形成的效果 ［J］．实用中西医结合临床，2016，16 （4）：50-51． ［14］张勇，王琛，王军，等．国产比伐卢定和普通肝素在急诊经皮冠状动脉介入治疗中的比较 ［J］．中国心血管杂志，2014，19 （2）：115-117． ［15］冯雪，李四维，李海霞，等．应用Sonoclot体外对比葛根素注射液与低分子肝素钠注射液的抗凝、抗血小板作用 ［J］．中国循证心血管医学杂志，2017，9 （2）：183-186．

相似文献/References:

[1]许雪如,魏冬梅,薛海琴,等.穴位按摩联合低分子肝素注射治疗妇科术后下肢深静脉血栓的效果[J].中国计划生育和妇产科,2015,(07):0.
　XU Xue-ru,WEI Dong-mei,XUE Hai-qin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(11):0.
[2]王晓燕,王秀.围生期孕产妇下肢深静脉血栓的临床特征、预后及影响因素分析[J].中国计划生育和妇产科,2016,(09):0.
　WANG Xiao-yan,WANG Xiu,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(11):0.
[3]杜振华*,魏茜雪.重组人促红素联合蔗糖铁治疗妇科恶性肿瘤相关性贫血的疗效及不良反应观察[J].中国计划生育和妇产科,2016,(12):21.
　DU Zhen-hua*,WEI Qian-xue.Observation of curative effect and adverse reaction of recombinant human erythropoietin combined with sucrose iron in the treatment of gynecological malignant tumor related anemia[J].Chinese Journal of Family Planning & Gynecotokology,2016,(11):21.
[4]樊国云.中医护理对妇科肿瘤患者术后的心理影响分析[J].中国计划生育和妇产科,2017,(10):68.
　FAN Guo-yun.Analysis of psychological influence of traditional Chinese medicine nursing on postoperative gynecological tumor patients[J].Chinese Journal of Family Planning & Gynecotokology,2017,(11):68.
[5]黄勇.妊娠期妇科肿瘤化疗的选择[J].中国计划生育和妇产科,2019,(2):24.
[6]黄俊花,段华*.Hippo-YAP信号通路参与妇科肿瘤的发生发展[J].中国计划生育和妇产科,2020,(2):29.

备注/Memo

备注/Memo:
2014年度南通市市级科技计划项目（项目编号：HS 2014074）
更新日期/Last Update: 2018-11-25